Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the fiscal year 2023, the global Parkinson’s disease market is poised to reach an impressive valuation of US$ 5.41 Billion, marking a significant rise from US$ 4.82 Billion in the previous fiscal year, 2022. Projections for the period from 2023 to 2033 indicate a robust and consistent growth pattern, with an anti...
The global Complicated Urinary Tract Infections Treatment Market size is expected to surpass an impressive valuation of USD 9.2 billion in 2023 and is projected to reach USD 16.1 billion by 2033, trailing a CAGR of 5.76%.An advanced platform called biosensors are used for the diagnosis of complicated urinary tract i...
In 2022, the global Antidiabetics Market is on track to achieve a valuation of US$ 89.2 billion, surging from the previous year’s figure of US$ 80.4 billion, reflecting a remarkable year-on-year growth rate of 10.9%. Looking ahead, the industry is poised to reach a substantial US$ 223 billion by 2032, marked by a ro...
The global Alpha-1 Antitrypsin Deficiency market is poised to achieve a market value of US$3 billion in 2023, with projections indicating a remarkable growth to US$10 billion by 2033, driven by a substantial CAGR of 12.8% during the forecast period. The surge in respiratory illnesses plays a pivotal role in expandin...
During the forecast period 2023 to 2033, the pituitary stalk interruption syndrome treatment market is expected to grow at a value of 3.5% CAGR, according to Future Market Insights. By the year 2033, the global market for pituitary stalk interruption syndrome treatment is expected to rise up to a market valuation of...